Nicotine Patch 14 mg

Natural health product licensed in Canada

Licence holder

Haleon Canada ULC

NPN or DIN-HM

80015460

Status

Inactive licence

Licence date

14 January 2010

Revision date

Not provided

Form

Timbre transdermique

Route of administration

Topique

Application type

TPD Cat IV/LS

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Copolymère d'acide méthacrylique, triglycérides à chaînes moyennes, Polyisobutylene

Recommended doses in Canada

Uses authorised in Canada

Text supplied in English because no French text is available.

Nicotine Patch is indicated as a temporary aid for those who want to stop smoking cigarettes or break the cigarette habit, when used as part of a smoking cessation program. To provide partial substitution for the nicotine in cigarettes in order to lessen withdrawal symptoms of smoking cessation. Nicotine patch is intended to be used as part of a smoking cessation strategy. The effectiveness of this product is directly related to your motivation to stop smoking. Consult your pharmacist or physician regarding the availability of smoking cessation programs in your area.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80015460

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.